4
17 Ratings with 4 written Reviews
Summary
Over the past 20 years Lila E. Nachtigall, M.D. has been involved in three areas of investigation. These include: 1) evaluating whether estrogen replacement therapy (ERT) reduces the risk of coronary heart disease and other cardiovascular in women; 2) determining whether estrogen replacement alone or estrogen progesterone replacement reduces the incidence of osteoporosis-related fractures and hip fractures; and 3) whether ERT increases the risk of endometrial cancer and whether progestin and estrogen replacement therapies (PERT) increase breast cancer risk.
Studies in these specific areas have been ongoing at NYU Medical Center since 1967. Dr. Nachtigall conducted a comprehensive ten year prospective double blind placebo controlled study of estrogen replacement therapy and the relationship to carcinoma, cardiovascular disease, and osteoporosis in a sample of hospitalized women. From the 300 women recruited, 168 were followed as matched pairs. This study was the first to demonstrate …the increased survival of patients on ERT, of lipid patterns as a significant risk factor, and of a reduction in breast cancer incidence in treated patients as compared to the controls. Moreover, a ten year follow-up with single photon densitometer measurements found continued increase in bone density in treated women who had their last menstrual period within three years or less, while those on placebo continued to lose bone. In addition, treated women who had their last menstrual period more than three years previously, kept their bone at a steady level, while their placebo controlled matched pairs continued to lose bone. Dr. Nachtigall subsequently conducted a 22 year follow-up on these studies, losing only five patients to follow-up or breast cancer.
Studies are continuing to address such issues as the efficacy of transdermal versus oral estrogen, the use of progesterone in prevention of endometrial cancer, the ability to decrease the side effects of progesterone therapy and on cardiovascular disease in older women, with and without hormones.
Read More Read less Studies in these specific areas have been ongoing at NYU Medical Center since 1967. Dr. Nachtigall conducted a comprehensive ten year prospective double blind placebo controlled study of estrogen replacement therapy and the relationship to carcinoma, cardiovascular disease, and osteoporosis in a sample of hospitalized women. From the 300 women recruited, 168 were followed as matched pairs. This study was the first to demonstrate …the increased survival of patients on ERT, of lipid patterns as a significant risk factor, and of a reduction in breast cancer incidence in treated patients as compared to the controls. Moreover, a ten year follow-up with single photon densitometer measurements found continued increase in bone density in treated women who had their last menstrual period within three years or less, while those on placebo continued to lose bone. In addition, treated women who had their last menstrual period more than three years previously, kept their bone at a steady level, while their placebo controlled matched pairs continued to lose bone. Dr. Nachtigall subsequently conducted a 22 year follow-up on these studies, losing only five patients to follow-up or breast cancer.
Studies are continuing to address such issues as the efficacy of transdermal versus oral estrogen, the use of progesterone in prevention of endometrial cancer, the ability to decrease the side effects of progesterone therapy and on cardiovascular disease in older women, with and without hormones.
Quick Facts
- 66 years of experience
- 12 insurance plans accepted
- speaks English
- New York University
- 4 written reviews
- 3 specialties
- 7 areas of expertise
- 1 hospital affiliation
- 2 office locations
- Female
Patients’ Perspective
- Gave an accurate diagnosis
- Had a good bedside manner
- Spent time with me
Based on patient feedback. Read the reviews
Office Locations
Dr. Lila S E Nachtigall has 2 locationsCompare with Similar Doctors
 |  |  |  |
| Dr. Lila S E Nachtigall, MD | Dr. Gabriela Beroukhim, MD | Dr. Owen Kidder Davis, MD | Dr. Farrah L Saleh, MD |
| Reproductive Endocrinology | Reproductive Endocrinology | Reproductive Endocrinology | Reproductive Endocrinology |
| Accepts New Patients | |||
| 66 Years of Experience | 7 Years of Experience | 44 Years of Experience | 7 Years of Experience |
| No Virtual Visit Option | Virtual Visit Available | Virtual Visit Available | Virtual Visit Available |
| Speaks English | Speaks English | Speaks English | Speaks English |
| New York , NY | Brooklyn , NY | New York , NY | New York , NY |
| Med School: New York Medical College | Med School: University Of California San Francisco School Of Medicine | Med School: Wake Forest School Of Medicine | Med School: Frank H Netter Md School Of Medicine At Quinnipiac University |
Current Profile | View Profile | View Profile | View Profile |
Insurance Plans Accepted by Dr. Lila S E Nachtigall
Medical Specialties
Dr. Lila S E Nachtigall has the following 3 specialties
Specialty Expertise
Dr. Lila S E Nachtigall has the following 7 areas of expertise
Certifications, License, & Education
66 Years Experience
Dr. Lila S E Nachtigall holds an active medical license in the state of New York.
Medical License
Medical Doctor with an active medical license in the state of New York that expires in 2027.
Education & Training
Residency
Completed their residency at New York University.
Medical School
Graduated from New York Medical College in 1960.
NPI Number
Dr. Nachtigall's NPI number is 1750443610.
Similar doctors
Frequently Asked Questions
- Does Dr. Lila S E Nachtigall accept virtual/telehealth appointments?
- Dr. Lila S E Nachtigall has not indicated that they accept virtual/teleheatlh appointments. Contact their office through their Vitals profile to check for availability.
- Where is Dr. Lila S E Nachtigall's office located?
- Dr. Lila S E Nachtigall's office is located at 550 1st Ave, New York, NY, 10016.
- Which hospitals is Dr. Lila S E Nachtigall affiliated with?
- Dr. Lila S E Nachtigall is affiliated with Nyu Tisch Hospital.
- Does Dr. Lila S E Nachtigall accept my insurance?
- You can see the insurance plans that Dr. Lila S E Nachtigall accepts on their Vitals profile.
- What languages does Dr. Lila S E Nachtigall speak?
- Dr. Lila S E Nachtigall speaks English.
Ensuring Data Transparency and Trust: A Guide to Vitals Doctor Listings and Reviews
Our provider data is gathered directly from physicians and publicly available databases. Providers who verify their profiles gain the ability to update information, offering additional details about their specialties,education, treated conditions, performed procedures, and accepted insurances.
Reviews on Vitals are submitted by users only. Recognizing the valuable insights these reviews offer into a doctor's reputation, we maintain internal policies and protocols to ensure the quality and accuracy of all reviews. Importantly, providers cannot delete or alter reviews independently. Reviews can only be deleted or changed following an internal assessment by our customer service team.
Your feedback is highly valued and we encourage you to contact our support team should you encounter any issues.
